TOKYO (Kyodo) -- A single course of newly approved Alzheimer's drug donanemab-azbt, the second medicine available in Japan ...

Donanemab became the second Alzheimer's drug that targets causative deposited plaque in the brain to win the coverage after ...

In Japan, clinical use is climbing faster, with about 4,500 people now on the drug. ARIA rates in Japan are half those in the U.S., which was also the case in the Phase 3 Clarity trial. Meanwhile, use ...

Eli Lilly has opened up a second market for its new Alzheimer's disease therapy Kisunla, after Japan followed the US in approving the drug. Kisunla (donanemab) is the second in a new generation of ...

The ministry intends to present its proposal to a government advisory council soon. All residents in Japan, regardless of their nationality, are required to pay into the national pension or ...

WASHINGTON (AP) — Japan has grounded its fleet of V-22 Osprey aircraft again after an incident last Sunday where one of the hybrid helicopter-aircraft tilted unexpectedly and hit the ground ...

The therapy was first approved in the U.S. in July 2024 and then approved in Japan in September 2024. In the U.S., donanemab treatment costs ~$78,000 per year when necessary scans and monitoring ...

TOKYO (AP) — Japan launched a defense satellite Monday aimed at speedier military operations and communication on a new flagship H3 rocket and successfully placed it into orbit, as the country ...